Delivery of polynucleotides using recombinant aav9
US2014199350A1
Chimeric topical vaccine for haemophilus influenzae-induced disease
US2014088511A1
Medical line securement system
EP3415167A1
Intrathecal delivery of recombinant adeno-associated virus 9
WO2013078316A1
Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotides
US2013130984A1
Administration Of Heparin Binding Epidermal Growth Factor For The Protection Of Enteric Neurons
WO2013067265A2
Improved spray device
US2014341880A1
Risk predictors for adverse perinatal outcomes
US2013039888A1
Products and methods for delivery of polynucleotides by adeno-associated virus for lysosomal storage disorders
KR20130040173A
Compositions and methods for the removal of biofilms
BR112012023967A2
compositions and methods for biofilm removal
WO2010071832A1
Delivery of polynucleotides across the blood brain barrier using recombinant aav9
US2009105188A1
Compositions and Methods for Treating Necrotizing Enterocolitis
EP2164860A2
Methods and compositions relating to viral fusion proteins
WO2008134635A1
Heparin binding epidermal growth factor (hb-egf) for use in methods of treating and preventing intestinal injury related to hemorrhagic shock and resuscitation
US2009169513A1
Expression of virus entry inhibitors and recombinant AAV therefor
WO2008067480A2
Myostatin inhibition for enhancing muscle and/or improving muscle function
WO2008067035A2
Unrestricted mutagenesis and cloning methods
US2010035973A1
Disruption of programmed death 1 (pd-1) ligand to adjuvant adeno-associated virus vector vaccines
CA2871088A1
Genes of an otitis media isolate of nontypeable haemophilus influenzae
